tiprankstipranks
BeOne Medicines (ONC)
NASDAQ:ONC
US Market
ONC
BeOne Medicines
RESEARCH TOOLSreports
Want to see ONC full AI Analyst Report?

BeOne Medicines (ONC) Income Statement

861 Followers

BeOne Medicines Income Statement

Last quarter (Q4 2025), BeOne Medicines's total revenue was $1.50B, an increase of 32.84% from the same quarter last year. In Q4, BeOne Medicines's net income was $66.50M. See BeOne Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.34B$ 3.81B$ 2.46B$ 1.42B$ 1.18B
Gross Profit
$ 4.67B$ 3.22B$ 2.08B$ 1.13B$ 1.01B
Operating Expenses
$ 4.23B$ 3.78B$ 3.29B$ 2.92B$ 2.45B
Depreciation and Amortization
$ 141.69M$ 171.76M$ 87.67M$ 66.28M$ 46.46M
EBITDA
$ 616.77M$ -396.44M$ -1.12B$ -1.72B$ -1.39B
Operating Income
$ 447.14M$ -568.20M$ -1.21B$ -1.79B$ -1.44B
Other Income/Expenses
$ -30.28M$ 35.20M$ 381.90M$ -171.37M$ 147.00K
Pretax Income
$ 416.85M$ -533.00M$ -825.84M$ -1.96B$ -1.44B
Net Income
$ 286.93M$ -644.79M$ -881.71M$ -2.00B$ -1.46B
Per Share Metrics
Basic EPS
$ 34.19$ -6.12$ -8.45$ -19.37$ -15.21
Diluted EPS
$ 32.89$ -6.12$ -8.45$ -19.37$ -15.21
Weighted Average Shares Outstanding
 109.06M 105.29M 104.39M 103.13M 92.79M
Weighted Average Shares Outstanding (Diluted)
 113.45M 105.29M 104.39M 103.13M 92.79M
Currency in USD

BeOne Medicines Earnings and Revenue History